News & Events
Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.
Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification
Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue
Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026
Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the
Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers
VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology
Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch
Vista, CA, and Albuquerque, NM, March 31, 2026 – Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO
Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality and poses a significant maternal risk due to potential co-occurrence with pre-eclampsia. Despite their impact,...
Learn More
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn More
High-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn More
Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx
HALO AP 2.5 introduces Lab Logic. A configuration layer that enables labs to tailor HALO AP® to their preferred workflow, enabling any lab, regardless of case volume, to operate like an automated triage engine, continuously analyzing incoming slides; triggering AI-driven actions; and delivering the right cases to the right experts
AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care
AI-powered digital pathology is redefining modern cancer care by extending clinical-grade insights beyond the microscope and enabling standardized, pixel-level analysis to support scalable cancer diagnostics anytime, anywhere.
KLAS Recognition as a Catalyst for What Comes Next
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily
Looking Back: Reviewing 2025 at Indica Labs
As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.
Advancing Neuroscience Research with HALO® and HALO AI
As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.
Announcing HALO® Muscle Fiber BF and Muscle Fiber FL Modules Supporting AI-Powered Segmentation and Interactive Markups
We’re excited to announce the launch of the newly updated Muscle Fiber BF and Muscle Fiber FL modules supporting AI nuclear segmentation, AI membrane segmentation, interactive markups, and new output metrics..
People of Pathology Podcast: Adam Smith – Making AI Accessible For All With Indica Labs
Adam Smith shares his journey from being a HALO® customer to helping lead Indica Labs’ mission of making AI accessible to pathologists everywhere.
12 Years of Digital Pathology Innovation and What to Expect Next
Kate Lillard Tunstall discusses Indica Lab’s 12-year journey in digital pathology, the impact of AI, and the future of the industry
HISTOHELP: ARTIFICIAL INTELLIGENCE – NOT SCARY AFTERALL!
Have you been listening to the National Society for Histotechnology HistoHelp podcast series? In their latest podcast, David Krull gives a great intro to AI for Digital Pathology. And even a shout out on the ease of use of HALO AI!
Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification
Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue specimens. Prostate Macrodissect AI is designed to operate in concert
Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx
HALO AP 2.5 introduces Lab Logic. A configuration layer that enables labs to tailor HALO AP® to their preferred workflow, enabling any lab, regardless of case volume, to operate like an automated triage engine, continuously analyzing incoming slides; triggering AI-driven actions; and delivering the right cases to the right experts
Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026
Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers
VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a
AACR 2026
19 – 22 April 2026 | Stop by our booth #4414 to see live demonstrations of HALO®, HALO AI, and HALO Link or prebook a meeting at our booth.
Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch
Vista, CA, and Albuquerque, NM, March 31, 2026 – Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO AP DX image management system designed for use with the
Webinars and Events
Check out our upcoming and most popular webinars and events!
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
Quantitative Digital Pathology: An Overview of the HALO® Image Analysis Platform
6 October 2022 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform, the gold standard analysis platform for quantitative tissue analysis in digital pathology.
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
Quantitative Digital Pathology: An Overview of the HALO® Image Analysis Platform
6 October 2022 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform, the gold standard analysis platform for quantitative tissue analysis in digital pathology.
All Webinars
Explore all of our upcoming and past webinars by category.
Present with Indica Labs
Interested in presenting your work using HALO software at an Indica Labs webinar or user group meeting? Fill out the form below!
You can also drop us an email at marketing@indicalab.com and let us know!